Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Mineralcorticoid Recept Antagonist on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia：A Multicenter Randomized Controlled Study

NCT05688579 is registered in ClinicalTrials.gov with Nanfang Li as lead sponsor.

NCT NCT05688579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05688579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Mineralcorticoid Recept Antagonist on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia：A Multicenter Randomized Controlled Study
Lead sponsor
Nanfang Li
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
April 16, 2023
Completion date
December 31, 2026
Enrollment
8,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperaldosteronaemia, hypertension